Skip to main content
Caplight Logo









Dash Bio

Dash Bio

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://www.dash.bio/

Last Round

Series A

Jul 14, 2026

Est. Valuation

$17.5M

Total Funding Raised

$17.5M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Dash Bio is a biotechnology company that provides an automated bioanalysis platform using AI and robotics to accelerate clinical drug development for pharmaceutical and biotech companies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Vertical SaaS, Data Governance

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

contract research organizationCRObioanalytical serviceslab automationtech-enabled CROautomated laboratoryqPCRELISALC-MSlaboratory data managementresearch data infrastructuredigital labvertical SaaSdrug discoverybioinformatics platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Dash Bio Comparables

Compare Dash Bio with similar companies based on industry and business-model similarity.

Dash Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Phylo
82%
Benchling
77%
TeselaGen Biotechnology
77%

Dash Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 14, 2026
Early FundingJul 23, 2025
SeedOct 24, 2024

Key People

Founding team and executive leadership

Ander Tallett

Co-Founder & COO

Founding Team

Dash Bio Investors

Notable investors and investment history

Dash Bio investors
InvestorRounds
Cybernetix VenturesEarly Funding
LifeX VenturesSeed, Early Funding
LifeX GlobalEarly Funding
Oak HC/FTSeries A
LifeX VenturesSeed, Early Funding
The Aligned FundEarly Funding
Freestyle VenturesEarly Funding, Series A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 23, 2026

    Grew 45% QoQ from 29 to 42 employees.

  • Jul 14, 2026

    $30M raised in early stage VC funding.

Dash Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Dash Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Dash Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range42
Year Founded2024
Last FundingJul 14, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?